专题：Inflammatory Myopathies and Dermatomyositis

This cluster of papers covers the epidemiology, classification, and clinical features of inflammatory myopathies such as dermatomyositis and polymyositis. It includes discussions on autoantibodies, interstitial lung disease, cancer risk, treatment strategies, myositis-specific antibodies, juvenile dermatomyositis, and the association with malignancy.
最新文献
Acquired cutaneous pseudoxanthoma elasticum progressing after chronic liver transplant rejection

article Full Text OpenAlex

Three distinct presentations of systemic sclerosis in patients with previous silica dust exposure

article Full Text OpenAlex

Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee

article Full Text OpenAlex

Myocarditis, Myositis, and Myasthenia Gravis

article Full Text OpenAlex

Robot-assisted surgery for rectal cancer with tumor-associated dermatomyositis during preoperative chemotherapy: A case report and literature review.

review Full Text OpenAlex

Paraneoplastic syndromes

book-chapter Full Text OpenAlex

Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis

review Full Text OpenAlex

Targeted immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies

review Full Text OpenAlex

Forehead subcutaneous fat atrophy following a single steroid injection for acute Brown syndrome

article Full Text OpenAlex

Inclusion body myositis

reference-entry Full Text OpenAlex

近5年高被引文献
Idiopathic inflammatory myopathies

review Full Text OpenAlex 493 FWCI16.076

New-onset IgG autoantibodies in hospitalized patients with COVID-19

article Full Text OpenAlex 412 FWCI88.908

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

article Full Text OpenAlex 203 FWCI37.675

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

article Full Text OpenAlex 203 FWCI27.704

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies

review Full Text OpenAlex 199 FWCI7.3

Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin

article Full Text OpenAlex 194 FWCI26.193

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

article Full Text OpenAlex 181 FWCI25.018

CD19-targeted CAR T cells in refractory antisynthetase syndrome

letter Full Text OpenAlex 178 FWCI0

Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease

article Full Text OpenAlex 160 FWCI23.171

Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis

review Full Text OpenAlex 157 FWCI5.953